Compounded GLP-1s and Drug Interactions: The Pharmacist Consultation You Should Use

Published July 17, 2026 · Medically reviewed content · Updated for 2026

Every medication you take by mouth passes through your stomach before it can be absorbed. GLP-1 receptor agonists fundamentally change how long that transit takes — slowing gastric emptying is one of their primary mechanisms for reducing appetite and improving blood sugar control. But that same mechanism means other oral medications may be absorbed differently: slower, less completely, or with altered peak concentrations.

This isn't a reason to avoid GLP-1 therapy. It's a reason to have a thorough conversation with your pharmacist — particularly the compounding pharmacist who understands both your GLP-1 formulation and the broader medication list.

How Delayed Gastric Emptying Affects Drug Absorption

Under normal conditions, oral medications dissolve in the stomach, pass into the small intestine, and are absorbed into the bloodstream within a relatively predictable timeframe. Drug manufacturers design their formulations — the tablet coating, the release mechanism, the recommended timing relative to food — based on this expected gastric transit time.

GLP-1 receptor agonists slow gastric emptying by 20% to 40% in clinical studies, with the most pronounced effect occurring during the initial weeks of treatment and at higher doses. This means oral medications may sit in the stomach longer, potentially delaying their absorption and shifting when peak blood levels occur.

For most medications, this delay is clinically insignificant — the total amount absorbed remains the same, just over a slightly longer window. But for drugs with narrow therapeutic windows — where the difference between an effective dose and a subtherapeutic or toxic dose is small — the change in absorption kinetics can matter.

Medications That Require Attention

Levothyroxine (Thyroid Hormone)

Levothyroxine is one of the most commonly co-prescribed medications for GLP-1 patients, as hypothyroidism and obesity frequently coexist. It also has a narrow therapeutic window and is highly sensitive to absorption timing. Delayed gastric emptying can reduce levothyroxine absorption, potentially leading to undertreated hypothyroidism.

The standard management: take levothyroxine first thing in the morning on an empty stomach, at least 30 to 60 minutes before other medications or food. If you inject your GLP-1 the previous evening, the delayed emptying effect should be at its lowest by morning. Monitor TSH levels more frequently during the first 3 to 6 months of GLP-1 therapy, and expect that your levothyroxine dose may need adjustment.

Oral Contraceptives

Delayed absorption of oral contraceptives doesn't necessarily reduce their total absorption, but it can shift peak levels. The clinical significance of this shift is debated — prescribing information for semaglutide notes that no clinically relevant interaction was observed in pharmacokinetic studies with combined oral contraceptives. However, patients relying on oral contraceptives as their sole form of birth control should discuss backup methods with their prescriber during the initial titration period, when gastric emptying effects are most variable.

Warfarin and Other Oral Anticoagulants

Warfarin has one of the narrowest therapeutic windows of any commonly prescribed medication. Changes in absorption timing can affect INR (International Normalized Ratio) readings and anticoagulation control. Patients on warfarin who start GLP-1 therapy should expect more frequent INR monitoring — especially during the first 8 to 12 weeks — and should not adjust their warfarin dose without guidance from their anticoagulation provider.

Direct oral anticoagulants (DOACs) like apixaban and rivarelbaan have somewhat wider therapeutic windows and are less affected by absorption timing changes, but monitoring during GLP-1 initiation is still reasonable.

Oral Diabetes Medications

Patients adding a GLP-1 agonist to an existing regimen of metformin, sulfonylureas, or SGLT2 inhibitors need monitoring for additive hypoglycemia — particularly with sulfonylureas, which stimulate insulin release independently of blood glucose. Your prescriber may reduce your sulfonylurea dose when starting a GLP-1 to avoid low blood sugar episodes.

Metformin's absorption may be slightly delayed but is generally not clinically affected. SGLT2 inhibitors have a wide enough therapeutic window that delayed gastric emptying is typically not a concern.

Acetaminophen and NSAIDs

Over-the-counter pain medications like acetaminophen show delayed peak concentrations when taken with GLP-1 agonists — meaning pain relief may take longer to onset. This isn't dangerous, but patients should be aware that their headache medication might take an extra 30 to 60 minutes to start working and should not take additional doses prematurely.

The Compounding Pharmacist's Role

Your compounding pharmacist has training and tools that your telehealth prescriber may not use in the same way. Specifically, pharmacists conduct drug utilization reviews (DURs) — systematic checks of your entire medication list against the new prescription for interactions, contraindications, and timing conflicts.

When you start a compounded GLP-1, your compounding pharmacy should receive your full medication list. If they don't ask for it, volunteer it. This isn't about being thorough for paperwork's sake — it's about catching interactions that may not have been flagged during a 15-minute telehealth visit focused on weight management.

What to Ask Your Pharmacist

• "Are there any timing conflicts between my GLP-1 injection schedule and my other medications?"
• "Should I adjust when I take my morning medications now that I'm on a GLP-1?"
• "Are there any medications on my list that need more frequent lab monitoring while I'm on this?"
• "The additives in my compounded formulation — do any of them interact with my other prescriptions?"

Additives in Compounded Formulations

Unlike commercially manufactured semaglutide (Ozempic/Wegovy), compounded formulations may contain additives beyond the active peptide — B12 (cyanocobalamin), glycine, vitamin B6, or other compounds added for stability or purported synergistic effects. These additives can themselves interact with other medications.

For example, high-dose vitamin B6 can reduce the effectiveness of levodopa (used for Parkinson's disease). Cyanocobalamin can interfere with certain lab tests. These interactions are uncommon, but they're exactly the kind of nuance that a pharmacist trained in compounding formulations is equipped to catch.

Timing Strategies That Minimize Interaction Risk

• Inject in the evening: If you take multiple morning oral medications, injecting your GLP-1 in the evening means the peak gastric emptying delay occurs overnight, when you're not taking other oral drugs
• Separate by 1–2 hours: For medications sensitive to absorption timing, take them at least 1 to 2 hours before your GLP-1 injection
• Front-load critical medications: Take narrow-window drugs (levothyroxine, warfarin) as the first oral medication of the day, before other pills and before meals
• Monitor and adjust: Expect that lab values for thyroid, anticoagulation, and blood sugar may shift during the first 3 months of GLP-1 therapy, and plan follow-up testing accordingly

Frequently Asked Questions